212 related articles for article (PubMed ID: 23287860)
1. Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.
Takahashi Y; Hori T; Cooper TK; Liao J; Desai N; Serfass JM; Young MM; Park S; Izu Y; Wang HG
Blood; 2013 Feb; 121(9):1622-32. PubMed ID: 23287860
[TBL] [Abstract][Full Text] [Related]
2. Sh3glb1/Bif-1 and mitophagy: acquisition of apoptosis resistance during Myc-driven lymphomagenesis.
Takahashi Y; Young MM; Serfass JM; Hori T; Wang HG
Autophagy; 2013 Jul; 9(7):1107-9. PubMed ID: 23680845
[TBL] [Abstract][Full Text] [Related]
3. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
[TBL] [Abstract][Full Text] [Related]
4. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
5. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Bouchard C; Lee S; Paulus-Hock V; Loddenkemper C; Eilers M; Schmitt CA
Genes Dev; 2007 Nov; 21(21):2775-87. PubMed ID: 17974917
[TBL] [Abstract][Full Text] [Related]
6. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
7. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
Frenzel A; Labi V; Chmelewskij W; Ploner C; Geley S; Fiegl H; Tzankov A; Villunger A
Blood; 2010 Feb; 115(5):995-1005. PubMed ID: 19965635
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.
Zwolinska AK; Heagle Whiting A; Beekman C; Sedivy JM; Marine JC
Oncogene; 2012 Jul; 31(28):3311-21. PubMed ID: 22081066
[TBL] [Abstract][Full Text] [Related]
9. BIF-1 inhibits both mitochondrial and glycolytic ATP production: its downregulation promotes melanoma growth.
Frangež Ž; Fernández-Marrero Y; Stojkov D; Seyed Jafari SM; Hunger RE; Djonov V; Riether C; Simon HU
Oncogene; 2020 Jun; 39(26):4944-4955. PubMed ID: 32493957
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
11. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
12. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
13. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
14. Bax interacting factor-1 promotes survival and mitochondrial elongation in neurons.
Wang DB; Uo T; Kinoshita C; Sopher BL; Lee RJ; Murphy SP; Kinoshita Y; Garden GA; Wang HG; Morrison RS
J Neurosci; 2014 Feb; 34(7):2674-83. PubMed ID: 24523556
[TBL] [Abstract][Full Text] [Related]
15. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.
Happo L; Phipson B; Smyth GK; Strasser A; Scott CL
Cell Death Dis; 2012 May; 3(5):e306. PubMed ID: 22573037
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.
Barna M; Pusic A; Zollo O; Costa M; Kondrashov N; Rego E; Rao PH; Ruggero D
Nature; 2008 Dec; 456(7224):971-5. PubMed ID: 19011615
[TBL] [Abstract][Full Text] [Related]
17. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
18. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys.
Livingston MJ; Wang J; Zhou J; Wu G; Ganley IG; Hill JA; Yin XM; Dong Z
Autophagy; 2019 Dec; 15(12):2142-2162. PubMed ID: 31066324
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
20. MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
Sun Y; Ji P; Chen T; Zhou X; Yang D; Guo Y; Liu Y; Hu L; Xia D; Liu Y; Multani AS; Shmulevich I; Kucherlapati R; Kopetz S; Sood AK; Hamilton SR; Sun B; Zhang W
J Pathol; 2017 Jan; 241(1):67-79. PubMed ID: 27741356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
